Cefiderocol: Clinical application and emergence of resistance
Drug Resistance Updates · 2024-01 · 72 · 101034
DOI: 10.1016/j.drup.2023.101034 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2024-01. Verfasst von Liang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China; MOE Key Laboratory of Geriatric Diseases and …. Hauptthemen laut MEDLINE: Cefiderocol, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 87 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China; MOE Key Laboratory of Geriatric Diseases and Immunology, The Second Affiliated Hospital of Soochow University, Suzh…
- Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Hackensack Meridian Health Center for Discovery and Innovation, Nutley, NJ, United States; Department of Medical Sciences, Hackensack Meridian School of Medicine, Nutley, NJ, United States.
Zitieren
APA
Wang, L., Zhu, J., Chen, L., & Du, H. (2024). Cefiderocol: Clinical application and emergence of resistance. Drug Resistance Updates, 72, 101034. https://doi.org/10.1016/j.drup.2023.101034
Vancouver
Wang L, Zhu J, Chen L, Du H. Cefiderocol: Clinical application and emergence of resistance. Drug Resistance Updates. 2024;72:101034. doi:10.1016/j.drup.2023.101034
BibTeX
@article{Wang2024,
author = {Wang, Liang and Zhu, Jie and Chen, Liang and Du, Hong},
title = {Cefiderocol: Clinical application and emergence of resistance},
journal = {Drug Resistance Updates},
year = {2024},
volume = {72},
pages = {101034},
doi = {10.1016/j.drup.2023.101034}
}
EUVIMED